FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3114312350> ?p ?o ?g. }

• W3114312350 endingPage "3841" @default.
• W3114312350 startingPage "3841" @default.
• W3114312350 abstract "Pediatric germ cell tumors (GCTs) are a group of chemosensitive malignancies with a 90% curability rate. We report a series of children with relapsing or therapy-resistant GCT treated with melphalan–etoposide–carboplatin high-dose chemotherapy (HDCT) and autologous stem cell transplantation. This consisted of 18 children, either with GCTs after relapse (nine patients) or with an unsatisfactory response to first-line chemotherapy (nine patients), who underwent HDCT. The HDCT regimens MEC1 (carboplatin 1500 mg/m2, etoposide 1800 mg/m2, and melphalan 140 mg/m2) and MEC2 (carboplatin 800 mg/m2, etoposide 800 mg/m2, and melphalan 140 mg/m2) were each used in nine patients. The median observation time was 81 months, the 5-year overall survival (OS) was 76%, and the event-free survival (EFS) was 70.8%. Non-relapse mortality was 0%, and four patients died after HDCT due to progression of the malignancy. No difference in OS or EFS was noted between the MEC1 and MEC2 protocols. The 5-year OS and 5-year EFS were higher in children treated with autologous stem cell transplantation before the age of four years. The presence of metastatic disease or time of HDCT consolidation during first/subsequent line chemotherapy did not affect patient survival. The melphalan–etoposide–carboplatin protocol is feasible in pediatric GCT, but is associated with potentially life-threatening complications. In conclusion, the use of HDCT must be examined in well-designed clinical trials, and the identification of patients who can benefit from this approach is critical to avoid overtreatment." @default.
• W3114312350 created "2021-01-05" @default.
• W3114312350 creator A5023317137 @default.
• W3114312350 creator A5029280043 @default.
• W3114312350 creator A5035974730 @default.
• W3114312350 creator A5041527330 @default.
• W3114312350 creator A5049917865 @default.
• W3114312350 creator A5054356659 @default.
• W3114312350 creator A5066394292 @default.
• W3114312350 creator A5067264689 @default.
• W3114312350 creator A5071590037 @default.
• W3114312350 date "2020-12-19" @default.
• W3114312350 modified "2023-10-04" @default.
• W3114312350 title "Melphalan, Etoposide, and Carboplatin Megatherapy with Autologous Stem Cell Transplantation in Children with Relapsing or Therapy-Resistant Extracranial Germ-Cell Tumors—A Retrospective Analysis" @default.
• W3114312350 cites W1829527967 @default.
• W3114312350 cites W1923058706 @default.
• W3114312350 cites W1933116774 @default.
• W3114312350 cites W1975135962 @default.
• W3114312350 cites W1980324865 @default.
• W3114312350 cites W1993197773 @default.
• W3114312350 cites W2010020291 @default.
• W3114312350 cites W2022026232 @default.
• W3114312350 cites W2039985726 @default.
• W3114312350 cites W2044851324 @default.
• W3114312350 cites W2048563157 @default.
• W3114312350 cites W2110945812 @default.
• W3114312350 cites W2126978371 @default.
• W3114312350 cites W2128723228 @default.
• W3114312350 cites W2139248078 @default.
• W3114312350 cites W2145586527 @default.
• W3114312350 cites W2149678989 @default.
• W3114312350 cites W2161239389 @default.
• W3114312350 cites W2163130660 @default.
• W3114312350 cites W2195354262 @default.
• W3114312350 cites W2241364267 @default.
• W3114312350 cites W2247463311 @default.
• W3114312350 cites W2280429454 @default.
• W3114312350 cites W2346075579 @default.
• W3114312350 cites W2555626407 @default.
• W3114312350 cites W2592061165 @default.
• W3114312350 cites W2748721357 @default.
• W3114312350 cites W2765537501 @default.
• W3114312350 cites W2783230990 @default.
• W3114312350 cites W2799295920 @default.
• W3114312350 cites W2801026019 @default.
• W3114312350 cites W2801520207 @default.
• W3114312350 cites W2951890881 @default.
• W3114312350 cites W2964995632 @default.
• W3114312350 cites W2971319283 @default.
• W3114312350 cites W2995997172 @default.
• W3114312350 cites W3031129122 @default.
• W3114312350 doi "https://doi.org/10.3390/cancers12123841" @default.
• W3114312350 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7765864" @default.
• W3114312350 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33352733" @default.
• W3114312350 hasPublicationYear "2020" @default.
• W3114312350 type Work @default.
• W3114312350 sameAs 3114312350 @default.
• W3114312350 citedByCount "4" @default.
• W3114312350 countsByYear W31143123502021 @default.
• W3114312350 countsByYear W31143123502022 @default.
• W3114312350 countsByYear W31143123502023 @default.
• W3114312350 crossrefType "journal-article" @default.
• W3114312350 hasAuthorship W3114312350A5023317137 @default.
• W3114312350 hasAuthorship W3114312350A5029280043 @default.
• W3114312350 hasAuthorship W3114312350A5035974730 @default.
• W3114312350 hasAuthorship W3114312350A5041527330 @default.
• W3114312350 hasAuthorship W3114312350A5049917865 @default.
• W3114312350 hasAuthorship W3114312350A5054356659 @default.
• W3114312350 hasAuthorship W3114312350A5066394292 @default.
• W3114312350 hasAuthorship W3114312350A5067264689 @default.
• W3114312350 hasAuthorship W3114312350A5071590037 @default.
• W3114312350 hasBestOaLocation W31143123501 @default.
• W3114312350 hasConcept C126322002 @default.
• W3114312350 hasConcept C141071460 @default.
• W3114312350 hasConcept C143998085 @default.
• W3114312350 hasConcept C2776694085 @default.
• W3114312350 hasConcept C2776938808 @default.
• W3114312350 hasConcept C2778119113 @default.
• W3114312350 hasConcept C2778239845 @default.
• W3114312350 hasConcept C2778684742 @default.
• W3114312350 hasConcept C2779050716 @default.
• W3114312350 hasConcept C2780775027 @default.
• W3114312350 hasConcept C2781451048 @default.
• W3114312350 hasConcept C2911091166 @default.
• W3114312350 hasConcept C71924100 @default.
• W3114312350 hasConceptScore W3114312350C126322002 @default.
• W3114312350 hasConceptScore W3114312350C141071460 @default.
• W3114312350 hasConceptScore W3114312350C143998085 @default.
• W3114312350 hasConceptScore W3114312350C2776694085 @default.
• W3114312350 hasConceptScore W3114312350C2776938808 @default.
• W3114312350 hasConceptScore W3114312350C2778119113 @default.
• W3114312350 hasConceptScore W3114312350C2778239845 @default.
• W3114312350 hasConceptScore W3114312350C2778684742 @default.
• W3114312350 hasConceptScore W3114312350C2779050716 @default.
• W3114312350 hasConceptScore W3114312350C2780775027 @default.
• W3114312350 hasConceptScore W3114312350C2781451048 @default.
• W3114312350 hasConceptScore W3114312350C2911091166 @default.
• W3114312350 hasConceptScore W3114312350C71924100 @default.

• next